SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
磊磊磊
Lv3
310 积分
2023-06-15 加入
最近求助
最近应助
互助留言
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
1天前
待确认
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
2天前
已完结
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
2天前
已完结
Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040
15天前
已完结
Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib
15天前
已完结
Relugolix: Five Reasons Why the US Food and Drug Administration Should Have Exercised Restraint
21天前
已完结
Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study
21天前
已完结
Efficacy and Safety of Radiotherapy Plus Relugolix in Men With Localized or Advanced Prostate Cancer
21天前
已完结
The Efficacy and Safety of Relugolix Compared with Degarelix in Advanced Prostate Cancer Patients: A Network Meta-analysis of Randomized Trials
21天前
已完结
Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials
21天前
已完结
没有进行任何应助
不需要了【积分已退回】
4个月前
不需要了【积分已退回】
4个月前
已找到【积分已退回】
5个月前
感谢,么么哒,点赞
11个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论